S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
NASDAQ:AGEN

Agenus Insider Trades

$5.90
-0.18 (-2.96 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.85
$6.09
50-Day Range
$4.98
$6.63
52-Week Range
$2.50
$6.79
Volume2.07 million shs
Average Volume4.11 million shs
Market Capitalization$1.38 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.35

Agenus (NASDAQ:AGEN) Insider Buying and Selling Activity

4.90% of Agenus' shares are owned by company executives, directors and other insiders. Over the past twelve months, Agenus insiders have sold shares 2 time(s), totalling $605,975.50. Insiders that have sold shares include Garo H Armen, and Christine M Klaskin.

Insider Buying and Selling by Quarter


Agenus (NASDAQ AGEN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2021Garo H ArmenCEOSell82,107$6.50$533,695.50852,880  
9/10/2021Christine M KlaskinInsiderSell11,120$6.50$72,280.00  
6/17/2020Corp IncyteMajor ShareholderSell214,000$3.66$783,240.0017,114,888  
6/15/2020Corp IncyteMajor ShareholderSell384,025$3.57$1,370,969.2517,580,093  
6/11/2020Corp IncyteMajor ShareholderSell183,875$3.77$693,208.7517,580,093  
12/12/2017Alex DuncanCTOSell6,546$3.46$22,649.1627,572  
12/12/2017Christine M KlaskinVPSell5,610$3.46$19,410.6069,943  
12/12/2017Karen ValentineInsiderSell8,358$3.46$28,918.68109,879  
10/30/2017Garo H ArmenCEOBuy100,000$3.55$355,000.00  
4/12/2017Garo H ArmenCEOBuy100,000$3.35$335,000.001,389,021  
2/14/2017Corp IncyteMajor ShareholderBuy10,000,000$6.00$60,000,000.0017,763,968  
9/6/2016Ulf WiinbergDirectorBuy30,000$6.29$188,700.0030,000  
5/9/2016Garo H ArmenCEOBuy100,000$3.18$318,000.001,346,026  
5/5/2016Ozer BaysalInsiderBuy2,250$3.10$6,975.0033,538  
3/7/2016Garo H ArmenCEOBuy200,000$4.03$806,000.001,251,228  
12/29/2015Garo H. ArmenCEOSell219,576$4.59$1,007,853.841,051,228  
12/28/2015Garo H. ArmenCEOSell134,352$4.60$618,019.201,051,228  
9/25/2015Charles Evan BallantyneCFOBuy10,000$5.05$50,500.0010,000  
9/25/2015Garo H ArmenCEOBuy100,000$5.03$503,000.001,409,607  
4/29/2015Shahzad MalikDirectorSell1,107,377$7.11$7,873,450.47  
1/9/2015Qvt Associates Gp LlcMajor ShareholderSell2,343,630$5.31$12,444,675.30  
1/23/2014Karen ValentineVPSell2,850$3.50$9,975.0051,534  
(Data available from 1/1/2013 forward)
speech bubbles
speech bubbles











Agenus (NASDAQ:AGEN) Insider Trade Frequently Asked Questions

Who is on Agenus's Insider Roster?

The list of insiders at Agenus includes Christine M Klaskin, Corp Incyte, and Garo H Armen.Learn more on AGEN's insiders

What percentage of Agenus stock is owned by insiders?

4.90% of Agenus stock is owned by insiders. Learn more on AGEN's insider holdings

Which Agenus insiders have been selling company stock?

The following insiders have sold Agenus stock in the last 24 months: Christine M Klaskin ($72,280.00), Corp Incyte ($2,847,418.00), and Garo H Armen ($533,695.50).

How much insider selling is happening at Agenus?

Insiders have sold a total of 875,127 Agenus shares in the last 24 months for a total of $3,453,393.50 sold.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.